April 21, 2018 7:59 AM ET

Life Sciences Tools and Services

Company Overview of KC Specialty Therapeutics, LLC

Company Overview

KC Specialty Therapeutics, LLC helps small start-up and large pharmaceutical companies in drug development. The company was founded in 2013 and is based in Kansas City, Kansas. KC Specialty Therapeutics, LLC operates as a subsidiary of Stason Pharmaceuticals, Inc.

2002 West 39th Avenue

Kansas City, KS 66103

United States

Founded in 2013



Key Executives for KC Specialty Therapeutics, LLC

KC Specialty Therapeutics, LLC does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

December 13, 2017
All assets of KC Specialty Therapeutics, LLC

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KC Specialty Therapeutics, LLC, please visit www.kcspecialty.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.